Dr. Dib is available for consulting with industry, hospitals and healthcare organizations. He has decades of experience helping the industry and hospitals with scientific strategy, product development, as well as, participating in IND (Investigational New Drug) development and IDE (Investigational Device Exception), the regulatory pathway for approval of a product, Phase I, II and III clinical trials and reimbursement strategies.

Dr. Nabil Dib, M.D., MSc, FACC is one of the world’s most renowned cardiovascular researchers and doctors. He completed his Interventional Cardiology Fellowship Program at Harvard Medical School, Beth-Israel-Deaconess Medical Center in Boston. Dr. Dib also completed an additional year in Investigational Devices at Harvard Medical School. Additionally, he continued his education at Harvard School of Public Health, where he obtained a degree in Master of Science in Epidemiology and Research, concentrated on a clinical trial designed and effectiveness.

He is an Associate Professor of Medicine and Director of Clinical Cardiovascular Cell Therapy, at University of San Diego, Director of Cardiovascular Stem Cell Consultants and Heart Sciences Center, President and Founder of the International Society for Cardiovascular Translational Research (ISCTR) and Founder and Editor in Chief of the Journal of Cardiovascular Translational Research.

For more than 25 years, Dr. Dib has been conducting research and developing the newest investigational treatments for advanced cardiovascular disease. He is internationally known and respected for his research and work regarding the use of adult stem cells to restore the health of patients with severe heart disease.

Dr Dib is currently the Director of Cardiovascular Research for Mercy Gilbert and Chandler Hospitals in Gilbert, Arizona.

Previous or Current Hospital/Industry Consulting Clients:
• Johnson & Johnson
• Boston Scientific
• Volcano
• Cardiovascular System Inc
• Shering Plough

To inquiry about Dr. Dib’s available for hospital or industry consulting, please contact DeAnn Dana at or